CTSK and pycnodysostosis: A study on the genetics and pathophysiology of pycnodysostosis revealed the role of cathepsin K in osteoclast activity that led to the development of cathepsin K inhibitors to treat osteoporosis by inhibiting osteoclastic bone resorption (105).